Moreover, STAT3 was found to be an Src-based activator of EGFR-triggered development of HNSCC in-vitro, inhibiting the apoptotic pathway and accelerating malignant progression in-vivo (Qureshy et al., 2022). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.